Author:
Huang Ke Nan,Grandi Sonia M.,Filion Kristian B.,Eisenberg Mark J.
Subject
Cardiology and Cardiovascular Medicine
Reference33 articles.
1. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents;Eisenberg;Circulation,2009
2. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;Lancet,2012
3. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials;Baber;J Am Coll Cardiol,2011
4. Abbott Laboratories. Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy. Available at: http://www.abbott.com/news-media/press-releases/abbotts-xience-prime-and-xience-v-drug-eluting-stents-receive-indication-in-europe-for-minimum-th.htm. Accessed August 28, 2012.
5. Clinical end points in coronary stent trials: a case for standardized definitions;Cutlip;Circulation,2007
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献